Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/9208
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMukherjee, Oishi-
dc.contributor.authorRakshit, Sudeshna-
dc.contributor.authorShanmugam, Geetha-
dc.contributor.authorSarkar, Koustav-
dc.date.accessioned2024-12-18T02:47:17Z-
dc.date.available2024-12-18T02:47:17Z-
dc.date.issued2023-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/9208-
dc.description.abstractThe immune system has a variety of potential effects on a tumor microenvironment and the course of chemotherapy may vary according to that. Anticancer treatments can encourage the release of unwanted signals from senescent tumor cells or the removal of immune-suppressive cells, which can lead to immune system activation. Hence, by inducing an immunological response and conversely making cancer cells more vulnerable to immune attack, chemotherapeutic agents can destroy cancer cells. Furthermore, chemotherapy can activate anticancer immune effectors directly or indirectly by thwarting immunosuppressive pathways. Therefore, in this review, we discuss how chemotherapeutic agents take part in immunomodulation and the molecular mechanisms underlying them. We also focus on the importance of carefully addressing the conflicting effects of chemotherapy on immune responses when developing successful combination treatments based on chemotherapy and immune modulatorsen_US
dc.subjectChemotherapy Immune system Anticancer treatment Immunosuppressive pathways Immunomodulationen_US
dc.titleRole of chemotherapeutic drugs in immunomodulation of canceren_US
dc.typeArticleen_US
Appears in Collections:VOL 4 2023

Files in This Item:
File Description SizeFormat 
14- 100068.pdf2.03 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.